Efficacy and safety of lixisenatide in the treatment of Type 2 diabetes mellitus: a review of Phase III clinical data

ISSN： 1744-6651

Source： Expert Review of Endocrinology and Metabolism, Vol.8, Iss.2, 2013-03, pp. : 105-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial

By Charbonnel B. Steinberg H. Eymard E. Xu L. Thakkar P. Prabhu V. Davies M. Engel S.

Diabetologia, Vol. 56, Iss. 7, 2013-07 ,pp. : 1503-1511

Springer Publishing Company

Access to resources Recommend Favorite

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

Current Diabetes Reviews, Vol. 13, Iss. 4, 2017-07 ,pp. : 405-423

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

By Raz I. Hanefeld M. Xu L. Caria C. Williams-Herman D. Khatami H.

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2564-2571

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Science of Type 2 Diabetes Mellitus

By Salans L.B.

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 1, 1998-01 ,pp. : 43-44

Elsevier

Access to resources Recommend Favorite

Treatment of Microalbuminuria in Patients with Type 2 Diabetes Mellitus

By Jerums G. MacIsaac R.J.

Treatments in Endocrinology, Vol. 1, Iss. 3, 2002-03 ,pp. : 163-173

Adis International

Access to resources Recommend Favorite